Journal scan
Drug treatment has little effect on hip fracture risk and may be a waste of money
The current focus on drug treatments to prevent hip fractures is neither viable as a public health strategy nor cost effective, suggests an analysis of the evidence by an international team of researchers.
![](https://stg.rcni.com/sites/rcn_nspace/files/styles/full_width_banner/public/RCNi_tile_content_1.png?itok=M52gLHIq)